跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg - SFDA Drug Approval Details
Approvals
/
SFDA
/
Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg
Authorized
NCE
Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
76c89eb797baa596
Company
Unknown
Type
NCE
Approval Details
Approval Id
76c89eb797baa596
Drug Approval Sfda Name
Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg
Trade Name
Zeposia (initiation pack) 4 caps 0.23 mg and 3 caps 0.46 mg
Generic Name
OZANIMOD
Register Number
0612234573
Register Year
2023
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
7
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
do not store above 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000002690-1-100000073375
Price
1114.2
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
76c89eb797baa596
Type
NCE
Back to SFDA Approvals